About
ELA (European Leukodystrophy Association) has funded a phase 2/3 clinical trial with MD1003 in adults for X-linked adrenoleukodystrophy. The company is developing relationships with other international patient associations.
ELA (European Leukodystrophy Association) has funded a phase 2/3 clinical trial with MD1003 in adults for X-linked adrenoleukodystrophy. The company is developing relationships with other international patient associations.